Ticker Details
Fortress Biotech, Inc. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products.
IPO Date:	December 1, 2011
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$104.29M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 3.64%
Avg Daily Range (30 D):	$0.14 | 3.83%
Avg Daily Range (90 D):	$0.10 | 3.20%

Institutional Daily Volume
Avg Daily Volume:	.16M
Avg Daily Volume (30 D):	1.36M
Avg Daily Volume (90 D):	.78M

Trade Size
Avg Trade Size (Sh.):	79
Avg Trade Size (Sh.) (30 D):	149
Avg Trade Size (Sh.) (90 D):	156

Institutional Trades
Total Institutional Trades:	37
Avg Institutional Trade:	$2.37M
Avg Institutional Trade (30 D):	$.81M
Avg Institutional Trade (90 D):	$.81M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.49M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	11.5K

News

Oct 1, 2025 @ 7:45 PM Fortress Biotech Investigated by the Portnoy Law F... Source: Lesley F. Portnoy

Oct 1, 2025 @ 12:00 PM Fortress Biotech and Cyprium Therapeutics Annou... Source: Fortress Biotech, Inc.

May 30, 2025 @ 2:47 PM Fortress Biotech Announces Closing of Sale of Subs... Source: Globe Newswire

May 7, 2025 @ 12:00 PM Fortress Biotech to Participate in the H.C. Wainwr... Source: N/A

Feb 10, 2025 @ 1:00 PM Mustang Bio Announces Closing of $8 Million Public... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$.13	$.5	$-.48
Diluted EPS	$.11	$.45	$-.48
Revenue	$17.63M	$16.41M	$13.14M
Gross Profit	$11.88M	$11.47M	$8.35M
Net Income / Loss	$8.83M	$-11.65M	$-24.69M
Operating Income / Loss	$-6.81M	$-36.47M	$-22.32M
Cost of Revenue	$5.76M	$4.94M	$4.79M
Net Cash Flow	$11.83M	$-16.95M	$33.74M
PE Ratio	32.45

Splits
Oct 10, 2023	1:15
Dec 06, 2022	1:10